Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 18, 2009

IDT Purchases VH Bio's Oligo Segment

  • Integrated DNA Technologies (IDT) acquired VH Bio’s oligonucleotide synthesis business. Since VH Bio is located in the U.K., and IDT is a Belgian company, the transaction will grow IDT’s customer base in the U.K.

    VH Bio will help IDT introduce its products to scientists in the U.K. Through the agreement, IDT will be able to offer a range of products with QC-checked sequences and next-day delivery.

    Joseph A. Walder, M.D., Ph.D., IDT’s founder and CEO, says that the deal is in line with the firm’s strategy to grow its product line and serve its customers. IDT has always understood the importance of quality, leading technology with the broadest scope, and truly collaborative customer service all at the lowest cost possible to the researcher, according to Dr. Walder.

    VH Bio retains a significant portfolio of products for immunologists and molecular biologists. These include HLA diagnostics, mAbs and lymphocyte separation products, as well as reagents and equipment.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »